You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CHOLAC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cholac, and what generic alternatives are available?

Cholac is a drug marketed by Alra and is included in one NDA.

The generic ingredient in CHOLAC is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cholac

A generic version of CHOLAC was approved as lactulose by HIKMA on July 3rd, 1995.

  Try a Trial

Drug patent expirations by year for CHOLAC
Recent Clinical Trials for CHOLAC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tampa General HospitalPhase 4

See all CHOLAC clinical trials

US Patents and Regulatory Information for CHOLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra CHOLAC lactulose SOLUTION;ORAL, RECTAL 071331-001 Jul 26, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.